Castle Biosciences' Return on Capital Employed fell 700.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.02% for FY2024, which is 1900.0% up from last year.
According to the latest figures from Q3 2025, Castle Biosciences' Return on Capital Employed is 0.07%, which was down 700.0% from 0.05% recorded in Q2 2025.
Castle Biosciences' 5-year Return on Capital Employed high stood at 0.02% for Q4 2024, and its period low was 0.25% during Q2 2023.
For the 5-year period, Castle Biosciences' Return on Capital Employed averaged around 0.1%, with its median value being 0.09% (2021).
Per our database at Business Quant, Castle Biosciences' Return on Capital Employed crashed by -1200bps in 2022 and then skyrocketed by 2100bps in 2024.
Over the past 5 years, Castle Biosciences' Return on Capital Employed (Quarter) stood at 0.09% in 2021, then tumbled by -85bps to 0.17% in 2022, then rose by 2bps to 0.17% in 2023, then soared by 111bps to 0.02% in 2024, then plummeted by -483bps to 0.07% in 2025.
Its last three reported values are 0.07% in Q3 2025, 0.05% for Q2 2025, and 0.03% during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value